NCT03573310: A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS |
|
|
| Active, not recruiting | 1 | 114 | Europe, Canada, US, RoW | JNJ-64619178 | Janssen Research & Development, LLC | Neoplasms, Solid Tumor, Adult, Non-Hodgkin Lymphoma, Myelodysplastic Syndromes | 12/24 | 12/24 | | |